Top Markets
#1 Siren Siren +31.61%
#2 OriginTrail OriginTrail +29.02%
#3 Tutorial Tutorial +14.64%
#4 Waves Waves +11.24%
#5 Cortex Cortex +11.09%
#6 Synapse Synapse +10.97%
#7 MarsCoin MarsCoin +9.27%
#8 Pons Pons +8.17%
#9 TROLL TROLL +6.05%
#10 Concordium Concordium +5.93%
Coin of the day
Siren Siren
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Rang in Aktien #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Aktienkurs
$0.49606484
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$88.47M
Veränderung (1 Tag)
-1.58%
Veränderung (1 Jahr)
-22.51%
Land
TW
Handel Intech Biopharm Corporation (6461)

Kategorie

Healthcare
Kursverlauf für Intech Biopharm Corporation (6461)
Höchster Schlusskurs: $0.51 am 2026-08-01

Niedrigster Schlusskurs: $2.53 am 2014-07-01
Kursverlauf der Aktie von Intech Biopharm Corporation von 2014 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 14.95%
2025 -41.62%
2024 -9.11%
2023 -16.45%
2022 54.36%
2021 -3.00%
2020 22.52%
2019 -6.95%
2018 -49.08%
2017 20.07%
2016 -28.29%
2015 0.41%
2014 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH